Edit Content

Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We have a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. 

Global Brain Tumor Drugs Market to reach USD 3.91 billion by the end of 2030

Global Brain Tumor Drugs Market Size Study & Forecast, by Therapy (Targeted Therapy, Chemotherapy, Immunotherapy, Others), by Indication (Pituitary, Meningioma, Glioma, Others), by Distribution Channel (Hospital Pharmacy, Retail & Online Pharmacy) and Regional Analysis, 2023-2030

Product Code: HLSDT-38060338
Publish Date: 15-11-2023
Page: 200

Global Brain Tumor Drugs Market is valued at approximately USD 1.80 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 10.2% over the forecast period 2023-2030. Brain tumors are abnormal growths of cells that develop in the brain or nearby areas. Tumors that develop in the brain is the primary brain tumor and tumor that begin in other parts of the body is known as secondary or metastatic brain tumors. The size of the tumor varies from very small size to large size. The increasing prevalence of brain tumors is a major contributing factor to the growth of the market. However, the high cost of treatments hinder market expansion.

The rising prevalence of brain cancer due to changing lifestyle habits, rapid urbanization, and increasing rate of active smokers is driving the market growth. According to Globocan 2020 estimates, there were 308,102 new cases of brain cancer worldwide in 2021, resulting in 251,329 new deaths. According to the American Cancer Society, around 24,530 malignant brain or spinal cord tumors were diagnosed in 2021, with an additional 3,460 children under the age of 15 expected to be diagnosed with brain or CNS tumors this year. The European Society for Medical Oncology (ESMO) has adopted a neurosurgery protocol to slow down tumor progression and provide a longer survival time, according to a research study titled “Brain Tumor Management Amidst COVID-19 Pandemic” in August 2020. The growing concern for the disease and its treatment is driving the market, along with key players investing in research and development. Furthermore, increasing government initiatives to provide a conducive environment for drug approval and the rising number of pharmaceutical companies developing these drugs propel the market growth. However, the side effects associated with these drugs hinder market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Brain Tumor Drugs Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 due to proper reimbursement policies in the U.S. and the increasing launch of new drugs. Asia Pacific is expected to grow significantly over the forecast period, due to varying regulatory policies and rising awareness about cancer and its types. According to the Brain Tumor Research Organization, Australia has average rating of brain tumor care was the lowest of all cancers, with a score of 8.37 out of 10.

Major market player included in this report are:
Johnson & Johnson Services, Inc.
Bayer AG
F. Hoffmann-La Roche Ltd
Eisai Co. Ltd
Novartis AG
Merck & Co. Inc.
Amgen Inc.
AstraZeneca PLC,
Pfizer, Inc.
GlaxoSmithKline PLC

Recent Developments in the Market:
Ø In November 2021, Pfizer Inc. acquired Trillium Therapeutics, a clinical-stage immuno-oncology company that focuses primarily on developing innovative therapies for the treatment of cancer.
Ø In September 2022, F. Hoffmann-La Roche Ltd. acquired Good Therapeutics, to gain rights to Good Therapeutics’ platform technology, which has applications in various fields such as autoimmune diseases, pain management, metabolic diseases, and cancer.

Global Brain Tumor Drugs Market Report Scope:
ü Historical Data – 2020 – 2021
ü Base Year for Estimation – 2022
ü Forecast period – 2023-2030
ü Report Coverage – Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
ü Segments Covered – Therapy, Indication, Distribution Channel, Region
ü Regional Scope – North America; Europe; Asia Pacific; Latin America; Middle East & Africa
ü Customization Scope – Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Therapy:
Targeted Therapy

By Indication:

By Distribution Channel:
Hospital Pharmacy
Retail & Online Pharmacy

By Region:

North America


Asia Pacific
South Korea

Latin America

Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Brain Tumor Drugs Market, by Region, 2020-2030 (USD Billion)
1.2.2. Brain Tumor Drugs Market, by Therapy, 2020-2030 (USD Billion)
1.2.3. Brain Tumor Drugs Market, by Indication, 2020-2030 (USD Billion)
1.2.4. Brain Tumor Drugs Market, by Distribution Channel, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Brain Tumor Drugs Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Brain Tumor Drugs Market Dynamics
3.1. Brain Tumor Drugs Market Impact Analysis (2020-2030)
3.1.1. Market Drivers Rising prevalence of brain cancer cases Increasing awareness about the disease Strong R&D initiatives from strong players
3.1.2. Market Challenges High Cost of Therapy Side effects associated with the treatment
3.1.3. Market Opportunities Increasing government initiatives Increasing rate of pharmaceutical companies that are developing these drugs
Chapter 4. Global Brain Tumor Drugs Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
Chapter 5. Global Brain Tumor Drugs Market, by Therapy
5.1. Market Snapshot
5.2. Global Brain Tumor Drugs Market by Therapy, Performance – Potential Analysis
5.3. Global Brain Tumor Drugs Market Estimates & Forecasts by Therapy 2020-2030 (USD Billion)
5.4. Brain Tumor Drugs Market, Sub Segment Analysis
5.4.1. Targeted Therapy
5.4.2. Chemotherapy
5.4.3. Immunotherapy
5.4.4. Others
Chapter 6. Global Brain Tumor Drugs Market, by Indication
6.1. Market Snapshot
6.2. Global Brain Tumor Drugs Market by Indication, Performance – Potential Analysis
6.3. Global Brain Tumor Drugs Market Estimates & Forecasts by Indication 2020-2030 (USD Billion)
6.4. Brain Tumor Drugs Market, Sub Segment Analysis
6.4.1. Pituitary
6.4.2. Meningioma
6.4.3. Glioma
6.4.4. Others
Chapter 7. Global Brain Tumor Drugs Market, by Distribution Channel
7.1. Market Snapshot
7.2. Global Brain Tumor Drugs Market by Distribution Channel, Performance – Potential Analysis
7.3. Global Brain Tumor Drugs Market Estimates & Forecasts by Distribution Channel 2020-2030 (USD Billion)
7.4. Brain Tumor Drugs Market, Sub Segment Analysis
7.4.1. Hospital Pharmacy
7.4.2. Retail & Online Pharmacy
Chapter 8. Global Brain Tumor Drugs Market, Regional Analysis
8.1. Top Leading Countries
8.2. Top Emerging Countries
8.3. Brain Tumor Drugs Market, Regional Market Snapshot
8.4. North America Brain Tumor Drugs Market
8.4.1. U.S. Brain Tumor Drugs Market Therapy breakdown estimates & forecasts, 2020-2030 Indication breakdown estimates & forecasts, 2020-2030 Distribution Channel breakdown estimates & forecasts, 2020-2030
8.4.2. Canada Brain Tumor Drugs Market
8.5. Europe Brain Tumor Drugs Market Snapshot
8.5.1. U.K. Brain Tumor Drugs Market
8.5.2. Germany Brain Tumor Drugs Market
8.5.3. France Brain Tumor Drugs Market
8.5.4. Spain Brain Tumor Drugs Market
8.5.5. Italy Brain Tumor Drugs Market
8.5.6. Rest of Europe Brain Tumor Drugs Market
8.6. Asia-Pacific Brain Tumor Drugs Market Snapshot
8.6.1. China Brain Tumor Drugs Market
8.6.2. India Brain Tumor Drugs Market
8.6.3. Japan Brain Tumor Drugs Market
8.6.4. Australia Brain Tumor Drugs Market
8.6.5. South Korea Brain Tumor Drugs Market
8.6.6. Rest of Asia Pacific Brain Tumor Drugs Market
8.7. Latin America Brain Tumor Drugs Market Snapshot
8.7.1. Brazil Brain Tumor Drugs Market
8.7.2. Mexico Brain Tumor Drugs Market
8.8. Middle East & Africa Brain Tumor Drugs Market
8.8.1. Saudi Arabia Brain Tumor Drugs Market
8.8.2. South Africa Brain Tumor Drugs Market
8.8.3. Rest of Middle East & Africa Brain Tumor Drugs Market

Chapter 9. Competitive Intelligence
9.1. Key Company SWOT Analysis
9.1.1. Company 1
9.1.2. Company 2
9.1.3. Company 3
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Johnson & Johnson Services, Inc. Key Information Overview Financial (Subject to Data Availability) Product Summary Recent Developments
9.3.2. Bayer AG
9.3.3. F. Hoffmann-La Roche Ltd
9.3.4. Eisai Co. Ltd
9.3.5. Novartis AG
9.3.6. Merck & Co. Inc.
9.3.7. Amgen Inc.
9.3.8. AstraZeneca PLC,
9.3.9. Pfizer, Inc.
9.3.10. GlaxoSmithKline PLC
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption

At Bizwit Research and Consultancy, we employ a thorough and iterative research methodology with the goal of minimizing discrepancies, ensuring the provision of highly accurate estimates and predictions over the forecast period. Our approach involves a combination of bottom-up and top-down strategies to effectively segment and estimate quantitative aspects of the market, utilizing our proprietary data & AI tools. Our Proprietary Tools allow us for the creation of customized models specific to the research objectives. This enables us to develop tailored statistical models and forecasting algorithms to estimate market trends, future growth, or consumer behavior. The customization enhances the accuracy and relevance of the research findings.
We are dedicated to clearly communicating the purpose and objectives of each research project in the final deliverables. Our process begins by identifying the specific problem or challenge our client wishes to address, and from there, we establish precise research questions that need to be answered. To gain a comprehensive understanding of the subject matter and identify the most relevant trends and best practices, we conduct an extensive review of existing literature, industry reports, case studies, and pertinent academic research.
Critical elements of methodology employed for all our studies include:
Data Collection:
To determine the appropriate methods of data collection based on the research objectives, we consider both primary and secondary sources. Primary data collection involves gathering information directly from various industry experts in core and related fields, original equipment manufacturers (OEMs), vendors, suppliers, technology developers, alliances, and organizations. These sources encompass all segments of the value chain within the specific industry. Through in-depth interviews, we engage with key industry participants, subject-matter experts, C-level executives of major market players, industry consultants, and other relevant experts. This allows us to obtain and validate critical qualitative and quantitative information while evaluating market prospects. AI and Big Data are instrumental in our primary research, providing us with powerful tools to collect, analyze, and derive insights from data efficiently. These technologies contribute to the advancement of research methodologies, enabling us to make data-driven decisions and uncover valuable findings.
In addition to primary sources, we extensively utilize secondary sources to enhance our research. These include directories, databases, journals focusing on related industries, company newsletters, and information portals such as Bloomberg, D&B Hoovers, and Factiva. These secondary sources enable us to identify and gather valuable information for our comprehensive, technical, market-oriented, and commercial study of the market. Additionally, we utilize AI algorithms to automate the collection of vast amounts of data from various sources such as surveys, social media platforms, online transactions, and web scraping. And employ Big Data technologies for storage and processing of large datasets, ensuring that no valuable information is missed during the data collection process.
Data Analysis:
Our team of experts carefully examine the gathered data using suitable statistical techniques and qualitative analysis methods. For quantitative analysis, we employ descriptive statistics, regression analysis, and other advanced statistical methods, depending on the characteristics of the data. This analysis may also incorporate the utilization of AI tools and big data analysis techniques to extract meaningful insights.
To ensure the accuracy and reliability of our findings, we extensively leverage data science techniques, which help us minimize discrepancies and uncertainties in our analysis. We employ Data Science to clean and preprocess the data, ensuring its quality and reliability. This involves handling missing data, removing outliers, standardizing variables, and transforming data into suitable formats for analysis. The application of data science techniques enhances our accuracy, efficiency, and depth of analysis, enabling us to stay competitive in dynamic market environments.
Market Size Estimation:
Our proprietary data tools play a crucial role in deriving our market estimates and forecasts. Each study involves the creation of a unique and customized model. The model incorporates the gathered information on market dynamics, technology landscape, application development, and pricing trends. AI techniques, such as machine learning and deep learning, aid us to analyze patterns within the data to identify correlations, trends, and relationships. By recognizing patterns in consumer behavior, purchasing habits, or market dynamics, our AI algorithms aid us in more precise estimations of market size. These factors are simultaneously analyzed within the model, allowing for a comprehensive assessment. To quantify their impact over the forecast period, correlation, regression, and time series analysis are employed.
To estimate and validate the market size, we employ both top-down and bottom-up approaches. The preference is given to a bottom-up approach, where key regional markets are analyzed as separate entities. This data is then integrated to obtain global estimates. This approach is crucial as it provides a deep understanding of the industry and helps minimize errors.
In our forecasting process, we consider various parameters such as economic tools, technological analysis, industry experience, and domain expertise. By taking all these factors into account, we strive to produce accurate and reliable market forecasts. When forecasting, we take into consideration several parameters, which include:
Market driving trends and favorable economic conditions
Restraints and challenges that are expected to be encountered during the forecast period.
Anticipated opportunities for growth and development
Technological advancements and projected developments in the market
Consumer spending trends and dynamics
Shifts in consumer preferences and behaviors.
The current state of raw materials and trends in supply versus pricing
Regulatory landscape and expected changes or developments.
The existing capacity in the market and any expected additions or expansions up to the end of the forecast period.
To assess the market impact of these parameters, we assign weights to each one and utilize weighted average analysis. This process allows us to quantify their influence on the market and derive an expected growth rate for the forecasted period. By considering these various factors and applying a weighted analysis approach, we strive to provide accurate and reliable market forecasts.
Insight Generation & Report Presentation:
After conducting the research, our experts analyze the findings in relation to the research objectives and the specific needs of the client. They generate valuable insights and recommendations that directly address the client’s business challenges. These insights are carefully connected to the research findings to provide a comprehensive understanding.
Next, we create a well-structured research report that effectively communicates the research findings, insights, and recommendations to the client. To enhance clarity and comprehension, we utilize visual aids such as charts, graphs, and tables. These visual elements are employed to present the data in an engaging and easily understandable format, ensuring that the information is accessible and visually appealing to the client. Our aim is to deliver a clear and concise report that conveys the research findings effectively and provides actionable recommendations to meet the client’s specific needs.

Need Assistance

Contact Person -
Krishant Mennon
Call us @
+ 91 99931 15879
Email: sales@bizwitresearch.com


Why Choose Us?

Quality over Quantity

Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.

Analyst Support

24x7 Chat Support plus
free analyst hours with every purchase

Flawless Methodology

Our 360-degree approach of market study, our research methods leave stones unturned.

Enquiry Now